Interleukin-la Reduces the Severity of the Vascular Leak Syndrome Produced by Interleukin-2 and Interleukin-2 Plus Interferon-a
- 1 July 1994
- journal article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 22 (4) , 381-397
- https://doi.org/10.1177/019262339402200404
Abstract
Histological and ultrastructural changes were investigated in lung, liver, and heart of mice given interleukin-2 (IL-2), either alone or in combination with other cytokines. IL-2 induced a vascular leak syndrome (VLS) of a moderate degree with infiltration of lymphoid cells, moderate endothelial damage. mild hepatic parenchymal damage, and minimal myocardial alterations. Interferon-a (IFN-α) produced infiltration mainly of monocytes/macrophages in liver and heart; endothelial cell damage was absent in lung and heart and minimal in liver. Interleukin-1α (IL-1α) caused an increased number of neutrophils in liver and lung; VLS and parenchymal cell and endothelial damage were not found. The VLS and the cellular damage caused by the combination of IL-2 and IFN were much more severe than those produced by IL-2 alone. In animals treated with IL-2, IFN-α, and IL-1α, VLS was minimal and parenchymal and endothelial cell damage were less severe than after IL-2 alone or IL-2 plus IFN-α. Taken together, these observations show that IL-1α reduces ultrastructural changes produced by IL-2 and IFN-α. This reduction may be clinically useful in the treatment of neoplasms.Keywords
This publication has 46 references indexed in Scilit:
- An ultrastructural study ofIn vivo interactions between lymphocytes and endothelial cells in the pathogenesis of the vascular leak syndrome induced by interleukin-2Cancer, 1991
- Myocarditis or acute myocardial infarction associated with interleukin-2 therapy for cancerCancer, 1990
- Combined effects of interferon α and interleukin 2 on the induction of a vascular leak syndrome in miceCancer Immunology, Immunotherapy, 1989
- The anti‐tumor effect of recombinant interferon alpha or gamma is influenced by tumor locationInternational Journal of Cancer, 1987
- In vivo anti‐tumor activity of combinations of interferon alpha and interleukin‐2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cellsInternational Journal of Cancer, 1987
- Clinical effects and toxicity of interleukin-2 in patients with cancerCancer, 1986
- High-Dose Recombinant Interleukin 2 in the Treatment of Patients With Disseminated CancerJAMA, 1986
- Interaction of recombinant interferons with recombinant interleukin-2: Differential effects on natural killer cell activity and interleukin-2-activated killer cellsInternational Journal of Cancer, 1986
- Inhibition of experimentally‐induced murine metastases by recombinant alpha interferon: Correlation between the modulatory effect of interferon treatment on natural killer cell activity and inhibition of metastasesInternational Journal of Cancer, 1984
- The Radioprotective Effect of Bacterial EndotoxinPublished by Springer Nature ,1983